Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-05-13 Purchase | 2021-05-17 07:00 am | Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director | 5,925,925 | $1.35 | $7,999,999 | 7,804,778 (Indirect) | View |
| 2020-11-17 Purchase | 2020-11-19 4:39 pm | Keros Therapeutics Inc. | KROS | Kariv Tomer Pontifax (Israel) IV L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax Late Stage Fund L.P. Pontifax Late Stage GP Ltd. Director 10% Owner | 60,000 | $50 | $3,000,000 | 155,262 (Indirect) | View |
| 2020-04-13 Purchase | 2020-04-13 5:13 pm | Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner | 437,499 | $16 | $6,999,984 | 149,262 (Indirect) | View |
| 2019-11-11 Purchase | 2019-11-13 7:10 pm | 89bio Inc. | ETNB | Kariv Tomer Pontifax (Israel) V L.P. Pontifax (Cayman) V L.P. Pontifax (China) V L.P. Pontifax 5 G.P. L.P. Pontifax Management 4 G.P. (2015) Ltd. Pontifax Late Stage GP Ltd. Pontifax Late Stage Fund L.P. Director 10% Owner | 250,000 | $16 | $4,000,000 | 1,134,671 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-30 Option Award | 2024-06-03 4:15 pm | N/A 2034-05-29 | Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:45 pm | N/A 2033-06-05 | Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-01-30 Option Award | 2023-01-31 4:08 pm | N/A 2033-01-30 | Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director | 2,859 | $0 | 2,859 (Direct) | View |
| 2022-11-29 Exercise | 2022-11-30 4:38 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner | 7,176 | $0.0001 | 1,226,412 (Indirect) | View |
| 2022-11-29 Exercise | 2022-11-30 4:38 pm | N/A 2023-10-07 | Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner | 7,176 | $0 | 1,226,412 (Indirect) | View |
Ownership(A) | 2022-11-30 4:34 pm | N/A 2023-10-07 | Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner | 0 | $0 | 7,176 (Indirect) | View |
| 2022-06-15 Option Award | 2022-06-17 08:24 am | N/A 2032-06-15 | Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:27 pm | N/A 2032-05-31 | Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner | 8,293 | $0 | 8,293 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 5:31 pm | N/A 2031-05-31 | Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner | 8,293 | $0 | 8,293 (Direct) | View |
| 2021-05-19 Option Award | 2021-05-20 4:10 pm | N/A 2031-05-19 | Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:10 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-04-13 Conversion | 2020-04-13 5:13 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner | 3,545,100 | $0 | 149,262 (Indirect) | View |
Ownership | 2020-04-07 7:30 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner | 0 | $0 | 4,297,008 (Indirect) | View |
| 2019-12-19 Option Award | 2019-12-20 8:00 pm | N/A 2029-12-19 | LogicBio Therapeutics Inc. | LOGC | Kariv Tomer Director | 10,869 | $0 | 10,869 (Direct) | View |
| 2019-11-13 Conversion | 2019-11-13 7:10 pm | N/A N/A | 89bio Inc. | ETNB | Kariv Tomer Pontifax (Israel) V L.P. Pontifax (Cayman) V L.P. Pontifax (China) V L.P. Pontifax 5 G.P. L.P. Pontifax Management 4 G.P. (2015) Ltd. Pontifax Late Stage GP Ltd. Pontifax Late Stage Fund L.P. Director 10% Owner | 6,384,672 | $0 | 1,134,671 (Indirect) | View |
Ownership | 2019-11-08 7:17 pm | N/A N/A | 89bio Inc. | ETNB | Kariv Tomer Pontifax (Israel) V L.P. Pontifax (Cayman) V L.P. Pontifax (China) V L.P. Pontifax 5 G.P. L.P. Pontifax Management 4 G.P. (2015) Ltd. Director 10% Owner | 0 | $0 | 884,671 (Indirect) | View |